Question 1

What are the potential benefits and risks of combining IRE and Pembrolizumab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer clinical trial (NCT06378047). Contact the study team or your healthcare provider for specific answers.

Question 2

How will this trial compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer clinical trial (NCT06378047). Contact the study team or your healthcare provider for specific answers.

Question 3

What kind of monitoring and tests will I need to undergo during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer clinical trial (NCT06378047). Contact the study team or your healthcare provider for specific answers.

Question 4

How long will I need to participate, and how often will I have to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer clinical trial (NCT06378047). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer clinical trial (NCT06378047). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer clinical trial (NCT06378047). Contact the study team or your healthcare provider for specific answers.

What this study is about